Eur Rev Med Pharmacol Sci 2021; 25 (13): 4445-4445
DOI: 10.26355/eurrev_202107_26232

Reply Letter – Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

S.A. Meo, D.C. Klonoff, J. Akram

Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. sultanmeo@hotmail.com/smeo@ksu.edu.sa

Free PDF Download

To cite this article

S.A. Meo, D.C. Klonoff, J. Akram
Reply Letter – Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 13
Pages: 4445-4445
DOI: 10.26355/eurrev_202107_26232

Keywords Related articles:

  1. Letter to editor on the paper entitled “Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19”
  2. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
  3. Reply Letter – COVID-19 (Novel Coronavirus 2019) – Recent trends
  4. Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”
  5. Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database